#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1794428	F	PUBCHEM_BIOASSAY: Inhibitors of Eya2ED: Hit Confirmation in Primary Screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488837, AID488939]		43		assay format	PubChem BioAssays
2.	ALA1614315	F	PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488939]	Homo sapiens	4,782		assay format	PubChem BioAssays
3.	ALA3214863	F	PubChem BioAssay. qHTS for Inhibitors of the Phosphatase Activity of Eya2: Confirmatory Assay for Cherry-picked Compounds. (Class of assay: confirmatory)		960		assay format	PubChem BioAssays
4.	ALA4257241	B	Inhibition of human Eya2 catalytic domain by p-nitrophenylphosphate assay	Homo sapiens	1		single protein format	Patent Bioactivity Data
5.	ALA4257245	B	Inhibition of human Eya2 catalytic domain using KKATOASQEpY phospho-peptide substrate	Homo sapiens	1		single protein format	Patent Bioactivity Data
6.	ALA4257253	B	Inhibition of Eya2 (unknown origin) expressed in human MCF10A cells assessed as reduction in cell migration	Homo sapiens	3		cell-based format	Patent Bioactivity Data
7.	ALA4257254	B	Inhibition of Eya2 (unknown origin) expressed in human MCF10A cells assessed as reduction in cell migration at 1 uM	Homo sapiens	1		cell-based format	Patent Bioactivity Data
8.	ALA4257255	B	Inhibition of Eya2 D250N mutant (unknown origin) expressed in human MCF10A cells assessed as reduction in cell migration	Homo sapiens	3		cell-based format	Patent Bioactivity Data
9.	ALA4422502	B	Inhibition of human Eya2 catalytic domain using para-nitrophenol phosphate substrate incubated for 30 mins	Homo sapiens	1		single protein format	Patent Bioactivity Data
10.	ALA4422505	B	Inhibition of human Eya2 catalytic domain using phospho-peptide KKATQASQEpY substrate	Homo sapiens	1		single protein format	Patent Bioactivity Data
11.	ALA4422513	B	Inhibition of EYA2 (unknown origin) stably transfected in human MCF10A cells assessed as inhibition of cell migration at 7.5 uM by transwell assay	Homo sapiens	3		cell-based format	Patent Bioactivity Data
12.	ALA4422514	B	Inhibition of EYA2 (unknown origin) stably transfected in human MCF10A cells assessed as inhibition of cell migration by transwell assay	Homo sapiens	3		cell-based format	Patent Bioactivity Data
13.	ALA4422515	B	Inhibition of EYA2 D250N mutant (unknown origin) stably transfected in human MCF10A cells assessed as inhibition of cell migration at 7.5 uM by transwell assay relative to control	Homo sapiens	3		cell-based format	Patent Bioactivity Data
14.	ALA4422540	B	Inhibition of EYA2 (unknown origin) stably transfected in human MCF10A cells assessed as inhibition of cell migration at 1 uM by transwell assay relative to control	Homo sapiens	1		cell-based format	Patent Bioactivity Data
15.	ALA4422541	B	Inhibition of GST-fused human Eya2 ED (253 to 538 residues) expressed in Escherichia coli pre-incubated for 10 mins followed by OMFP substrate addition and further incubated for 30 mins by fluorescence based assay relative to control	Homo sapiens	3		assay format	Patent Bioactivity Data
16.	ALA4422542	B	Inhibition of GST-fused human Eya2 ED (253 to 538 residues) expressed in Escherichia coli pre-incubated for 10 mins followed by OMFP substrate addition and further incubated for 30 mins by fluorescence based assay	Homo sapiens	20		assay format	Patent Bioactivity Data
17.	ALA4422543	B	Inhibition of GST-fused human Eya2 ED (253 to 538 residues) expressed in Escherichia coli at 0.1 to 100 mM pre-incubated for 10 mins followed by OMFP substrate addition and further incubated for 30 mins by fluorescence based assay	Homo sapiens	5		assay format	Patent Bioactivity Data
18.	ALA4422544	B	Inhibition of GST-fused human Eya2 ED (253 to 538 residues) expressed in Escherichia coli assessed as reduction in phosphatase activity using OMFP as substrate in presence of 1 mM MgCl2 by FITS assay	Homo sapiens	1		assay format	Patent Bioactivity Data
19.	ALA4422545	B	Inhibition of GST-fused human Eya2 ED (253 to 538 residues) expressed in Escherichia coli assessed as reduction in phosphatase activity using OMFP as substrate in presence of 5 uM MgCl2 by FITS assay	Homo sapiens	1		assay format	Patent Bioactivity Data
20.	ALA4422546	B	Inhibition of GST-fused human Eya2 ED (253 to 538 residues) expressed in Escherichia coli assessed as reduction in phosphatase activity using OMFP as substrate in absence of MgCl2 by FITS assay	Homo sapiens	1		assay format	Patent Bioactivity Data